#Zatrudniamy na stanowisko Kierownik biura w Warszawie. Aplikuj dzisiaj lub udostępnij tę publikację swojej sieci. Zgłoszenia przyjmujemy na adres: [email protected]
Informacje
Quantum was designed to create technologies that solve concrete problems in cardiac surgery, cardiology and respiratory medicine. The primary objective of Quantum devices is to increase the safety of invasive procedures performed in worldwide cardiac surgical centers. First, we focus on highest volume procedures because supporting these will have the most significant impact on population health. We identify critical problems in medical procedures and therapy processes. We design the solution, organize specialist teams, and conduct the projects. Quantum uses scientific methodology to analyze and monitor the global market, population status, public health dynamics, progress in medicines, therapy guidelines, and incoming technologies. Quantum cooperates with universities, laboratories, medical device manufactures, patent attorneys, and venture and seed funds.
- Witryna
-
www.quantuminnovations.pl
Link zewnętrzny organizacji Quantum Innovations
- Branża
- Badania w zakresie biotechnologii
- Wielkość firmy
- 2–10 pracowników
- Siedziba główna
- Warszawa
- Rodzaj
- Spółka prywatna
Lokalizacje
-
Główna
Poleczki
19
02-822 Warszawa, PL
Pracownicy Quantum Innovations
Aktualizacje
-
Quantum Innovations ponownie to opublikował(a)
A majority of U.S. surgeons believe their operating rooms are outdated, according to a new survey performed by Medtronic. Many say this issue is impacting patient care and contributing to burnout. Vipul Patel, MD, executive director of the Society of Robotic Surgery | SRS shared his thoughts.
-
Quantum Innovations ponownie to opublikował(a)
🚀 𝐐𝐮𝐚𝐧𝐭𝐮𝐦 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧𝐬 𝐑𝐚𝐢𝐬𝐞𝐬 €9.4𝐌 𝐭𝐨 𝐋𝐚𝐮𝐧𝐜𝐡 𝐆𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬! 📢 Warsaw-based MedTech pioneer, #QuantumInnovations, has secured €9.4 million in a funding round spearheaded by Vinci IQ ASI, with continued support from MedTech Holding. The latest round of funding will enable the company to conduct crucial trials and secure certification to bring their innovations to global markets. 🌎 The cutting-edge solutions from Quantum Innovations, Heart Sense and Heart Guard, represent a major development in cardiac care. 🏥 These innovations allow for real-time ECG monitoring and metabolic tracking during surgeries, filling a critical gap in current medical technology. With over 20.5 million deaths annually attributed to cardiovascular diseases worldwide, the impact of these innovations is sure to be transformative. 💪 Quantum Innovations' technologies promise not only to enhance the precision and success of cardiac surgeries, but also hold the potential to significantly reduce complications and perioperative mortality rates associated with heart surgery. 🔗 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐠𝐫𝐨𝐮𝐧𝐝𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐢𝐦𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐜𝐚𝐫𝐝𝐢𝐚𝐜 𝐬𝐮𝐫𝐠𝐞𝐫𝐲 𝐡𝐞𝐫𝐞: https://lnkd.in/dnUZh-75! Grzegorz Suwalski, Chris Cabrera, Sian Faye Sukhai, Michel Le Tyrant, Shahroze Jamil #MedicalTechnology #CardiacCare #HealthcareInnovation #MedTech #TechSocialImpactSpotlight
-
-
Quantum Innovations ponownie to opublikował(a)
Quantum Innovations secures €10M funding led by Vinci IQ ASI and MedTech Holding Sp. z o.o., empowering CEO Grzegorz Suwalski to advance cutting-edge cardiac surgery technology globally. #MedTech #Innovation https://lnkd.in/gzUEJfqP
Quantum Innovations Secures €10M to Pioneer Cardiac Surgery Technology -
https://thetimesmag.com
-
Quantum Innovations ponownie to opublikował(a)
Polish medtech Quantum Innovations has raised €9.4 million in its second funding round led by Vinci IQ ASI with participation from the company’s existing investor MedTech Holdings 🇵🇱💡 “Acquiring new and previously inaccessible precise signals from the organs and body parts undergoing surgery pushes the boundaries of our knowledge. Overcoming these barriers opens up prospects for improving medical procedures,” explained Grzegorz Suwalski, Founder and CEO of Quantum Innovations. https://lnkd.in/dnUZh-75
Warsaw-based Quantum Innovations raises €9.4 million to develop cardiac surgery monitoring tech | EU-Startups
https://www.eu-startups.com
-
Quantum Innovations ponownie to opublikował(a)
Mamy przyjemność poinformować o pierwszej inwestycji funduszu Vinci IQ, zarządzanego przez Vinci S.A., w spółkę Quantum Innovations. QI to polski start-up MedTechowy, który rozwija innowacyjną technologię sensorów pozwalającą na monitorowanie narządów poddawanych zabiegom kardiochirurgicznym. 💔 ➡ 💖 Spółka pozyskała łącznie kapitał w kwocie 41 milionów PLN w obecnej rundzie finansowania - prowadzonej przez fundusz Vinci IQ ASI. Zostanie on przeznaczony na stworzenie własnej linii produkcyjnej, przeprowadzenie badań regulatorowych i klinicznych, certyfikację oraz wprowadzenie na główne rynki światowe. Dziękujemy za zaufanie oraz liczymy na owocną współpracę Grzegorz Suwalski, Przemysław Furdal, Pawlos Mandzios oraz Andrzej Morawiec. 🤝 Gratulacje również dla Zespołu VINCI - Piotr Woliński, Marcin Adamczyk, Tomasz Serwan, Monika Prokopowicz, Piotr Jusiński, Karolina Izydorek, Anna Stępień, dla Łukasz Łyszczarek z kancelarii LLW | Lewczuk Łyszczarek Szymczyk oraz zespołu Grant Thornton Poland za wsparcie w procesie inwestycyjnym. 👋 Link do artykułu: https://lnkd.in/daRMzux6 #QuantumInnovations #startup #inwestcyja #VinciIQ #gratulujemy
41 milionów złotych dla Quantum Innovations na rozwój technologii kardiochirurgicznych. Głównym inwestorem Vinci IQ ASI
https://mamstartup.pl
-
Quantum Innovations, a Warsaw-based medtech startup, has secured €10 million in its second funding round to develop cardiac surgery technology. The company, led by Grzegorz Suwalski develops Heart Sense, a unique sensor technology for monitoring organs during surgery and transplantation, enabling real-time ECG monitoring and tracking tissue metabolism ⚡️ https://ain.social/3KQqUXX #news #Poland #medtech #investments
-
-
TRIAL ON 70,000 PATIENTS: STILL NO WINNER BETWEEN ON-PUMP and OFF-PUMP CORONARY BYPASS SURGERY The study just published in the American Journal of Cardiology included data from 22 different trials. There is no winner but the recommendations from researchers are important: “Specialized training and expertise in revascularization procedures could foster innovation, improve outcomes, and enhance patient safety. Moreover, the emphasis should not solely be on the technical aspects but also on patient selection, perioperative care, and long-term follow-up.” So our teams from Heart Sense and CorFlow are working on “game-changers” - technologies supporting less invasive OPCAB technique. Source: On-pump vs. off-pump CABG: No difference in long-term mortality, meta-analysis confirms (cardiovascularbusiness.com). More information at: www.heartsense.pl and www.corflowmed.com
Cardiovascular Business | Homepage
cardiovascularbusiness.com
Podobne strony
Finansowanie
Ostatnia runda
Zamienny skrypt dłużny10 161 012,00 USD
Inwestorzy